Peptide-based pharmaceutical products
The company develops peptide-based pharmaceutical products targeting neurodegenerative conditions.
Source: LinkedIn company description · Retrieved October 13, 2026
NeuroScientific Biopharmaceuticals Ltd is an Australian drug development company developing peptide-based pharmaceutical products.
Its therapeutic indications include Alzheimer’s disease, multiple sclerosis, glaucoma and post-Covid lung fibrosis. The company is committed to a methodically planned, efficiently executed and risk-aware research and development program.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company develops peptide-based pharmaceutical products targeting neurodegenerative conditions.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 15, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 2, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 15, 2026, September 18, 2026, September 19, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.